IMMUNOMEDICS INC's ticker is and the CUSIP is 452907908. A total of 2 filers reported holding IMMUNOMEDICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $71,468,000 | +442.8% | 840,500 | +126.2% | 0.22% | +267.2% |
| Q2 2020 | $13,166,000 | +1000.8% | 371,500 | +318.8% | 0.06% | +510.0% |
| Q1 2020 | $1,196,000 | -87.8% | 88,700 | -80.9% | 0.01% | -85.1% |
| Q4 2019 | $9,801,000 | +78.3% | 463,200 | +11.7% | 0.07% | +52.3% |
| Q3 2019 | $5,496,000 | +2.4% | 414,500 | +7.1% | 0.04% | -10.2% |
| Q2 2019 | $5,366,000 | +7.2% | 386,900 | +48.5% | 0.05% | -12.5% |
| Q1 2019 | $5,004,000 | -56.4% | 260,500 | -67.6% | 0.06% | -43.4% |
| Q4 2018 | $11,467,000 | +20.6% | 803,600 | +76.0% | 0.10% | +32.0% |
| Q3 2018 | $9,509,000 | -35.6% | 456,500 | -26.8% | 0.08% | -40.5% |
| Q2 2018 | $14,756,000 | +40.7% | 623,400 | -13.2% | 0.13% | +18.9% |
| Q1 2018 | $10,487,000 | -57.9% | 717,800 | -53.4% | 0.11% | -39.4% |
| Q4 2017 | $24,898,000 | +43.0% | 1,540,700 | +23.7% | 0.18% | +10.8% |
| Q3 2017 | $17,416,000 | +54.1% | 1,245,800 | -2.7% | 0.16% | +35.0% |
| Q2 2017 | $11,301,000 | +79.4% | 1,279,800 | +31.5% | 0.12% | +60.3% |
| Q1 2017 | $6,299,000 | +129.6% | 973,500 | +30.3% | 0.07% | +170.4% |
| Q4 2016 | $2,743,000 | +492.4% | 747,400 | +424.1% | 0.03% | +440.0% |
| Q3 2016 | $463,000 | -40.0% | 142,600 | -57.1% | 0.01% | -44.4% |
| Q2 2016 | $772,000 | -0.5% | 332,700 | +7.2% | 0.01% | -18.2% |
| Q1 2016 | $776,000 | +53.1% | 310,300 | +87.9% | 0.01% | +83.3% |
| Q4 2015 | $507,000 | -17.6% | 165,100 | -53.8% | 0.01% | -33.3% |
| Q3 2015 | $615,000 | -68.8% | 357,700 | -26.3% | 0.01% | -67.9% |
| Q2 2015 | $1,972,000 | +196.1% | 485,600 | +179.2% | 0.03% | +180.0% |
| Q1 2015 | $666,000 | -53.9% | 173,900 | -42.2% | 0.01% | -54.5% |
| Q4 2014 | $1,445,000 | +70.6% | 301,100 | +32.3% | 0.02% | +69.2% |
| Q3 2014 | $847,000 | -12.0% | 227,600 | -13.7% | 0.01% | -13.3% |
| Q2 2014 | $962,000 | -29.9% | 263,600 | -19.2% | 0.02% | -34.8% |
| Q1 2014 | $1,373,000 | -74.8% | 326,100 | -72.4% | 0.02% | -72.0% |
| Q4 2013 | $5,439,000 | +32.8% | 1,182,300 | +78.7% | 0.08% | +5.1% |
| Q3 2013 | $4,095,000 | +3.2% | 661,600 | -9.3% | 0.08% | -20.4% |
| Q2 2013 | $3,968,000 | – | 729,400 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 661,600 | $4,095,000 | 0.08% |
| Citadel Advisors | 41,800 | $259,000 | 0.00% |